Any feedback?
Literature summary for 3.4.15.1 extracted from
- Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series (2010), Ann. Emerg. Med., 56, 278-282.
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| lung | - |
Homo sapiens | - |
General Information
| General Information | Comment | Organism |
|---|---|---|
| malfunction | ACE induces angioedema, mainly mediated by bradykinin-induced activation of vascular bradykinin B2 receptors. Icatibant, a bradykinin B2 receptor antagonist, acts as therapeutic drug in treatment of ACE-induced angioedema | Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
